首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿托伐他汀对自发性高血压大鼠心肌组织PPARs表达的影响
引用本文:陈红娟,陈君柱,王兴祥,余敏.阿托伐他汀对自发性高血压大鼠心肌组织PPARs表达的影响[J].中国病理生理杂志,2008,24(6):1069-1073.
作者姓名:陈红娟  陈君柱  王兴祥  余敏
作者单位:浙江大学医学院第一附属医院心内科,浙江 杭州 310003
摘    要:目的: 探讨阿托伐他汀对自发性高血压大鼠心肌组织PPARs(peroxisome proliferator-activated receptors, PPARs)表达的影响及其对心肌肥厚的逆转作用与可能机制。方法: 自发性高血压大鼠分为阿托伐他汀灌胃治疗组(SHR-A,30 mg·kg-1·d-1)及模型组(SHR),治疗8周,同周龄Wistar-Kyoto 鼠为正常血压对照组。治疗前及治疗后2、4、8周测量大鼠尾动脉血压。治疗后测血浆血脂水平,以心脏组织病理分析判断心肌肥厚,Western blotting 检测心肌组织PPARα、PPARγ的表达水平。结果: 经过8周治疗, SHR-A组及SHR组血压及血脂水平无明显差异(P>0.05)。SHR-A组左室重量指数低于SHR组(P<0.01)。在SHR-A组,PPARα及PPARγ表达高于SHR组(P<0.01)。结论: 阿托伐他汀显著改善自发性高血压大鼠心肌组织PPARs表达,有效逆转左室肥厚,可能与其降压及降脂作用无关。

关 键 词:阿托伐他汀  肥大  左心室  过氧化酶体激增剂活化受体  
收稿时间:2006-12-28
修稿时间:2007-9-17

Effects of atorvastatin on myocardium expression of peroxisome proliferator-activated receptors in spontaneously hypertensive rats
CHEN Hong-juan,CHEN Jun-zhu,WANG Xing-xiang,YU Min.Effects of atorvastatin on myocardium expression of peroxisome proliferator-activated receptors in spontaneously hypertensive rats[J].Chinese Journal of Pathophysiology,2008,24(6):1069-1073.
Authors:CHEN Hong-juan  CHEN Jun-zhu  WANG Xing-xiang  YU Min
Institution:Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. E-mail:cch87019@163.com
Abstract:AIM: To investigate the effects of atorvastatin on myocardium peroxisome proliferator-activated receptors (PPARs) expression, regression of left ventricular hypertrophy, and the possible mechanisms in spontaneously hypertensive rats (SHR). METHODS: 16 nine-week-old male spontaneously hypertensive rats were randomly divided into two groups: SHR received atorvastatin at dose of 30 mg·kg-1·d-1 by oral gavage once daily for 8 weeks (SHR-A, n=8), and SHR received vehicle (0.9% saline) as controls (SHR, n=8). Age-matched Wistar-kyoto rats received vehicle for 8 weeks were served as normaltensive controls (WKY, n=8). Systolic blood pressure was measured at the beginning, 2, 4 and 8 weeks of the experiment. At the end of the experiment, plasma lipid levels were measured. Left ventricular hypertrophy was accessed by pathological analysis. The expressions of PPARα and PPARγ were investigated by the method of Western blotting. RESULTS: There was not much difference of systolic blood pressure and plasma lipid levels between SHR-A and SHR group (P>0.05). Compared with SHR group, left ventricular weight mass index decreased significantly in SHR-A group (P<0.01). The myocardium PPARα and PPARγ expression increased significantly (P<0.01). CONCLUSION: Atorvastatin regresses left ventricular hypertrophy and increases myocardium PPARα and PPARγ expression in spontaneously hypertensive rats, which is independent of its lipid-lowering activity.
Keywords:Atorvastatin  Hypertrophy  left ventricular  Peroxisome proliferator-activated peceptor
本文献已被 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号